Aubrey Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Aubrey Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,800	Closed	-$139K	–	57
2022 Q4	$139K	Hold	3,800	–	–	0.11%	46
2022 Q3	$179K	Hold	3,800	–	–	0.15%	44
2022 Q2	$272K	Hold	3,800	–	–	0.22%	45
2022 Q1	$308K	Buy	3,800 +1,200	+46%	+$102K	0.18%	52
2021 Q4	$267K	Hold	2,600	–	–	0.1%	38
2021 Q3	$227K	Hold	2,600	–	–	0.07%	39
2021 Q2	$233K	Hold	2,600	–	–	0.07%	41
2021 Q1	$197K	Hold	2,600	–	–	0.06%	45
2020 Q4	$177K	Hold	2,600	–	–	0.04%	50
2020 Q3	$138K	Hold	2,600	–	–	0.04%	49
2020 Q2	$151K	Hold	2,600	–	–	0.07%	45
2020 Q1	$102K	Buy	+2,600	New	+$152K	0.06%	45

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Aubrey Capital Management's SYNH Position: Q1 2023 in Review

Aubrey Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 3,800 shares — an estimated $139K sold.

Aubrey Capital Management first reported a position in SYNH in Q1 2020 and held it in 12 quarters. The position peaked at $308K in Q1 2022. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

Aubrey Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Aubrey Capital Management sold 3,800 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $139K.
Aubrey Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2020 and held it in 12 quarters.
Aubrey Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $308K in Q1 2022.
305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Aubrey Capital Management's 13F filing for Q1 2023, filed 24 Apr 2023.